ストックスクリーナーアプリを入手
2.28
3.80%
-0.09
前日終値:
$2.37
開ける：
$2.38
24時間の取引高:
2.23M
Relative Volume:
1.82
時価総額：
$156.64M
収益：
$832.00K
当期純損益:
$-135.12M
株価収益率:
-0.3744
EPS:
-6.09
ネットキャッシュフロー:
$-124.69M
1週間 パフォーマンス:
+10.68%
1か月 パフォーマンス:
+28.09%
6か月 パフォーマンス:
+16.92%
1年 パフォーマンス:
+23.58%
1日の値動き範囲:
$2.26
$2.42
1週間の範囲:
$2.03
$2.72
52週間の値動き範囲:
$1.30
$2.9789
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
名前
Inovio Pharmaceuticals Inc
セクター
電話
(858) 410-3134
住所
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
INO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
2.28 | 162.83M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.20 | 113.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
767.96 | 78.69B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.23 | 52.32B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.99 | 52.15B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.84 | 35.52B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-09 | 開始されました | Piper Sandler | Overweight |
| 2024-05-14 | 開始されました | Stephens | Overweight |
| 2024-01-25 | アップグレード | Oppenheimer | Perform → Outperform |
| 2022-11-09 | ダウングレード | Maxim Group | Buy → Hold |
| 2022-11-01 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-07-19 | 再開されました | RBC Capital Mkts | Sector Perform |
| 2022-05-11 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-01-21 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-12-29 | 再開されました | Jefferies | Hold |
| 2021-09-10 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-06-24 | 開始されました | Jefferies | Hold |
| 2021-03-23 | 開始されました | BofA Securities | Neutral |
| 2021-02-12 | 開始されました | Oppenheimer | Outperform |
| 2020-11-17 | ダウングレード | ROTH Capital | Neutral → Sell |
| 2020-11-10 | アップグレード | ROTH Capital | Sell → Neutral |
| 2020-09-28 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-28 | アップグレード | Maxim Group | Hold → Buy |
| 2020-07-01 | ダウングレード | Maxim Group | Buy → Hold |
| 2020-07-01 | ダウングレード | ROTH Capital | Neutral → Sell |
| 2020-06-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-06-26 | ダウングレード | Stifel | Buy → Hold |
| 2020-05-21 | 開始されました | The Benchmark Company | Buy |
| 2020-04-30 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2020-03-13 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-03-13 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-12-19 | 開始されました | ROTH Capital | Buy |
| 2018-02-15 | 繰り返されました | Maxim Group | Buy |
| 2017-10-18 | 開始されました | RBC Capital Mkts | Outperform |
| 2017-09-06 | 開始されました | Citigroup | Buy |
| 2017-06-08 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2017-05-24 | 繰り返されました | Maxim Group | Buy |
| 2017-03-16 | アップグレード | Maxim Group | Hold → Buy |
| 2017-03-16 | ダウングレード | Piper Jaffray | Overweight → Neutral |
すべてを表示
Inovio Pharmaceuticals Inc (INO) 最新ニュース
Biotech firm INOVIO gives new hire 24,000 stock options - Stock Titan
Why Inovio Pharmaceuticals Inc. (GBM) stock trades below fair valueQuarterly Market Review & Detailed Earnings Play Strategies - Bölüm Sonu Canavarı
Will Inovio Pharmaceuticals Inc. stock deliver long term returnsPortfolio Performance Summary & Free Safe Entry Trade Signal Reports - DonanımHaber
Is Inovio Pharmaceuticals Inc. (GBM) stock a top dividend aristocrat candidate2025 Technical Overview & Accurate Intraday Trading Signals - Улправда
Aug Spikes: Can Inovio Pharmaceuticals Inc. (GBM) stock attract analyst upgradesJuly 2025 News Drivers & AI Based Buy and Sell Signals - Улправда
INOVIO’s Future: Investor Insights - StocksToTrade
Inovio Pharmaceuticals (NASDAQ:INO) Stock Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
JANUS HENDERSON GROUP PLC Expands Stake in Inovio Pharmaceuticals Inc - GuruFocus
Inovio Pharmaceuticals Inc Stock Analysis and ForecastMomentum Trading Signals & Free Double Digit Growth Tips - earlytimes.in
INO Stock: Inovio’s FDA BLA Milestone, New Equity Offerings and 2026 Catalyst – Latest News and Forecasts (December 7, 2025) - ts2.tech
Inovio Pharmaceuticals (NASDAQ:INO) Shares Pass Above 200-Day Moving AverageTime to Sell? - MarketBeat
Will Inovio Pharmaceuticals Inc. stock see insider buying2025 Market Trends & Weekly Watchlist for Hot Stocks - Newser
How Inovio Pharmaceuticals Inc. stock performs in weak economyWeekly Trade Analysis & Fast Gaining Stock Reports - Newser
Inovio Pharmaceuticals drops 6%, proposes equity offering - MSN
Can Inovio Pharmaceuticals Inc. (GBM) stock surprise markets with earningsJuly 2025 Rallies & Stock Timing and Entry Methods - Newser
Inovio Pharmaceuticals Inc. Stock Advances 5.2%, Outperforms Market - 富途牛牛
Will Inovio Pharmaceuticals Inc. (GBM) stock beat value stocksEarnings Performance Report & Weekly Stock Performance Updates - Newser
Is Inovio Pharmaceuticals Inc. (GBM) stock good for wealth creationTrade Risk Report & Free Long-Term Investment Growth Plans - Newser
How reliable is Inovio Pharmaceuticals Inc. (GBM) stock dividend growthMarket Movement Recap & Stepwise Trade Signal Implementation - Newser
Is Inovio Pharmaceuticals Inc. (GBM) stock expanding market penetrationDollar Strength & High Conviction Investment Ideas - Newser
INO: INO-3107 shows strong efficacy and safety in RRP, with launch preparations underway for 2025 - TradingView — Track All Markets
Trend Recap: Will Inovio Pharmaceuticals Inc stock see insider buying2025 Volatility Report & Low Risk High Win Rate Picks - BỘ NỘI VỤ
Is Inovio Pharmaceuticals Inc. (GBM) stock a fit for income portfoliosJuly 2025 Trends & AI Based Buy/Sell Signal Reports - Newser
Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults (PR Newswire) - Aktiellt
INOVIO Maps Out High-Stakes December as Investors Eye Rare Disease Catalysts - MyChesCo
INOVIO Shares Drop 10% After Discounted $25 Million Public Offering - MSN
What analysts say about Inovio Pharmaceuticals Inc GBM stockStock Buyback Updates & High Return Portfolio Growth - earlytimes.in
How strong is Inovio Pharmaceuticals Inc. (GBM) stock earnings growth2025 Analyst Calls & Low Risk High Reward Ideas - newser.com
What sentiment indicators say about Inovio Pharmaceuticals Inc. stockWeekly Stock Report & Daily Oversold Bounce Ideas - newser.com
Will Inovio Pharmaceuticals Inc. (GBM) stock gain from lower interest ratesWeekly Stock Report & Low Risk High Win Rate Stock Picks - newser.com
INOVIO Advances Toward First Commercial Product as BLA Filing Caps Pivotal Quarter - MyChesCo
Why Inovio Pharmaceuticals Inc. stock is favored by top institutions2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
Is Inovio Pharmaceuticals Inc. stock supported by strong cash flowsWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
Why analysts maintain buy rating on Inovio Pharmaceuticals Inc. (GBM) stockMarket Growth Review & Weekly Return Optimization Alerts - newser.com
HC Wainwright Issues Optimistic Forecast for INO Earnings - MarketBeat
Published on: 2025-11-20 00:40:52 - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock survive global slowdownTrend Reversal & Low Volatility Stock Recommendations - newser.com
Will Inovio Pharmaceuticals Inc. (GBM) stock attract long term capital inflows2025 Volatility Report & Low Drawdown Trading Techniques - newser.com
Is Inovio Pharmaceuticals Inc. (GBM) stock inflation resilientEarnings Growth Report & Risk Adjusted Buy/Sell Alerts - newser.com
Analyzing Inovio Pharmaceuticals Inc. with multi timeframe chartsDollar Strength & AI Enhanced Execution Alerts - newser.com
What is the fair value estimate for Inovio Pharmaceuticals Inc. (GBM) stock in 2025 - newser.com
Inovio Pharmaceuticals Inc (INO) 財務データ
収益
当期純利益
現金流量
EPS
0.44%
大文字化:
|
ボリューム (24 時間):